Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(8%)
Results Posted
75%(6 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
2
15%
Ph phase_4
3
23%
Ph phase_2
3
23%
Ph not_applicable
5
38%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
5(38.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Terminated1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (23.1%)
Phase 32 (15.4%)
Phase 43 (23.1%)
N/A5 (38.5%)

Trials by Status

terminated18%
active_not_recruiting18%
unknown215%
enrolling_by_invitation18%
completed862%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
13